Since the last time you logged in our privacy statement has been updated. We want to ensure that you are kept up to date with any changes and as such would ask that you take a moment to review the changes. You will not continue to receive KPMG subscriptions until you accept the changes.
We want to make sure you're kept up to date. Please take a moment to review these changes. You will not receive KPMG subscription messages until you agree to the new policy.
BMA Covid-19 updates
BMA is updating their regulations due to COVID-19. Read how.
March 20: Industry notice Coronavirus (COVID-19) Economic Substance - The Registrar of Companies acknowledges the current extraordinary circumstances arising from the global Covid-19 response. In relation to the application of the economic substance requirements pursuant to the Economic Substance Act 2018, and in line with the principles set out in the applicable Guidance Notes, the Registrar will take all appropriate circumstances into account in assessing compliance. As such, where meetings or other similar compliance measures are not possible due to necessary travel or quarantine restrictions, this may be taken into account. As with all information evidencing compliance, entities should keep careful records of all such circumstances, and should continue in good faith to ensure their ongoing compliance with the economic substance requirements as set out in the legislation and Guidance Notes.
March 18: Covid-19 Notice - On Thursday, February 6, 2020 the BMA activated its Business Continuity Plan in an effort to limit their employee exposure to COVID-19 by implementing social distancing protocols through remote working options and virtual conferencing alternatives for all non-critical external meetings.